|
Delayed
Börse Stuttgart
11:02:46 25/09/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 34.02 EUR | -0.64% |
|
-2.12% | +36.96% |
| 18/09 | EU Medicines Agency Panel Issues Positive Opinion on Gedeon Richter's Arthritis Drug | MT |
| 12/08 | Gedeon Richter PLC, Q2 2026 Earnings Call, Aug 07, 2026 |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 2,175.59 | +17.61% | 32 | ||||||
| 14,433.33 | +30.74% | 12 | ||||||
| 1,197.45 | +1.45% | 30 | ||||||
| 1,509.08 | +7.87% | 36 | ||||||
| 257.83 | -0.83% | 6 | ||||||
| 2,497.73 | +2.77% | 11 | ||||||
| 13,214.57 | +4.46% | 7 | ||||||
| - | 2,508.33 | +4.19% | 12 | |||||
| - | - | - | - | - | ||||
| 3,796.46 | +7.26% | 13 | ||||||
| 172.67 | +8.84% | 3 | ||||||
| - | - | - | - | - | ||||
| - | - | 133.12 | +2.33% | 2 | ||||
| - | 154.68 | +19.08% | 4 | |||||
| - | - | 14.6 | +9.36% | 1 | ||||
| - | 2,765 | -3.52% | 2 | |||||
| Average | 3,202.18 | +7.97% | 12 | ||||||
| Weighted average by Cap. | 5,247.92 | +14.49% | 20 |
- Stock Market
- Stocks
- RICHTER Stock
- RIG2 Stock
- Sector Gedeon Richter
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
